ClinicalTrials.Veeva

Menu

Growth Hormone Treatment in Short Children Born Small for Gestational Age

Lilly logo

Lilly

Status and phase

Completed
Phase 3

Conditions

Infant, Small for Gestational Age

Treatments

Drug: somatropin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00191529
B9R-EW-GDGB
6581

Details and patient eligibility

About

Comparison of 2 different doses of human growth hormone treatment on change in height after 1 and 2 years of treatment.

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Born small for gestational age
  • actual body height less than or equal -3 SDS
  • chronological age greater than 3 years

Exclusion criteria

  • Growth hormone deficiency
  • any defined syndromal disease
  • Diabetes mellitus

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems